Vanguard Group’s Ocean Bio-Chem Inc OBCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-155,540
| Closed | -$2M | – | 4644 |
|
|
2022
Q2 | $2M | Hold |
155,540
| – | – | ﹤0.01% | 3810 |
|
|
2022
Q1 | $1.27M | Hold |
155,540
| – | – | ﹤0.01% | 4138 |
|
|
2021
Q4 | $1.35M | Hold |
155,540
| – | – | ﹤0.01% | 4171 |
|
|
2021
Q3 | $1.47M | Hold |
155,540
| – | – | ﹤0.01% | 4154 |
|
|
2021
Q2 | $1.9M | Sell |
155,540
-56,814
| -27% | -$726K | ﹤0.01% | 3976 |
|
|
2021
Q1 | $2.55M | Hold |
212,354
| – | – | ﹤0.01% | 3806 |
|
|
2020
Q4 | $2.84M | Buy |
212,354
+4,423
| +2% | +$63.4K | ﹤0.01% | 3565 |
|
|
2020
Q3 | $2.98M | Buy |
207,931
+33,660
| +19% | +$510K | ﹤0.01% | 3370 |
|
|
2020
Q2 | $2.43M | Buy |
174,271
+69,941
| +67% | +$467K | ﹤0.01% | 3381 |
|
|
2020
Q1 | $506K | Buy |
104,330
+60,318
| +137% | +$227K | ﹤0.01% | 3670 |
|
|
2019
Q4 | $146K | Hold |
44,012
| – | – | ﹤0.01% | 3974 |
|
|
2019
Q3 | $150K | Hold |
44,012
| – | – | ﹤0.01% | 3992 |
|
|
2019
Q2 | $145K | Hold |
44,012
| – | – | ﹤0.01% | 4016 |
|
|
2019
Q1 | $150K | Buy |
44,012
+600
| +1% | +$2.18K | ﹤0.01% | 3965 |
|
|
2018
Q4 | $142K | Buy |
43,412
+2,004
| +5% | +$7.33K | ﹤0.01% | 3947 |
|
|
2018
Q3 | $169K | Hold |
41,408
| – | – | ﹤0.01% | 4024 |
|
|
2018
Q2 | $149K | Hold |
41,408
| – | – | ﹤0.01% | 4016 |
|
|
2018
Q1 | $165K | Buy |
41,408
+8,100
| +24% | +$32.3K | ﹤0.01% | 3979 |
|
|
2017
Q4 | $145K | Buy |
33,308
+6,497
| +24% | +$29.4K | ﹤0.01% | 3969 |
|
|
2017
Q3 | $135K | Buy |
26,811
+2,206
| +9% | +$9.47K | ﹤0.01% | 3967 |
|
|
2017
Q2 | $101K | Buy |
24,605
+1,033
| +4% | +$4.59K | ﹤0.01% | 3984 |
|
|
2017
Q1 | $110K | Buy |
23,572
+700
| +3% | +$2.97K | ﹤0.01% | 3979 |
|
|
2016
Q4 | $86K | Buy |
22,872
+11,630
| +103% | +$38.5K | ﹤0.01% | 3986 |
|
|
2016
Q3 | $32K | Buy |
11,242
+100
| +0.9% | +$247 | ﹤0.01% | 4057 |
|
|
2016
Q2 | $26K | Hold |
11,142
| – | – | ﹤0.01% | 4111 |
|
|
2016
Q1 | $26K | Hold |
11,142
| – | – | ﹤0.01% | 4113 |
|
|
2015
Q4 | $24K | Hold |
11,142
| – | – | ﹤0.01% | 4167 |
|
|
2015
Q3 | $29K | Hold |
11,142
| – | – | ﹤0.01% | 4164 |
|
|
2015
Q2 | $40K | Buy |
11,142
+700
| +7% | +$2.67K | ﹤0.01% | 4168 |
|
|
2015
Q1 | $44K | Buy |
+10,442
| New | +$50K | ﹤0.01% | 4130 |
|
Vanguard Group's OBCI Position: Q3 2022 in Review
Vanguard Group sold out of Ocean Bio-Chem Inc (OBCI) in Q3 2022, closing a stake of 155,540 shares — an estimated $2M sold.
Vanguard Group first reported a position in OBCI in Q1 2015 and held it in 30 quarters. The position peaked at $2.98M in Q3 2020. 0 funds tracked by Wall St. Rank hold OBCI as of Q3 2022.
- Vanguard Group reported no remaining Ocean Bio-Chem Inc position as of Q3 2022 after selling out during the quarter.
- Vanguard Group sold 155,540 Ocean Bio-Chem Inc shares in Q3 2022, an estimated $2M.
- Vanguard Group first reported a position in Ocean Bio-Chem Inc in Q1 2015 and held it in 30 quarters.
- Vanguard Group's Ocean Bio-Chem Inc position peaked at $2.98M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Ocean Bio-Chem Inc as of Q3 2022.
Based on Vanguard Group's 13F filing for Q3 2022, filed 14 Nov 2022.